Cassava Sciences(SAVA)
搜索文档
Cassava Sciences (SAVA) Investor Presentation - Slideshow
2022-04-02 02:32
CASSAVA We Focus on Alzheimer's disease March 2022 Forward-Looking Statements & Safe Harbor This presentation contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that may include but are not limited to: our strategy and plans; the size and scope of our pivotal Phase 3 trial and its likelihood of success; the interpretation of clinical data generated in interim analyses of an open-label study, plans to ...
Cassava Sciences (SAVA) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
2019-09-17 00:49
Remi Barbier - President & CEO Corporate Overview September 2019 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statement about our prospects for growth, intellectual property protection, market size, competitive position, regulatory agency action, and the anticipated development, timing, data readouts and therapeutic scope and value of our development stage products. You should not place ...
Cassava Sciences (SAVA) Presents At Maxim Group's Alzheimer's Disease Conference - Slideshow
2019-06-28 02:12
NASDAQ: SAVA CORPORATE OVERVIEW June 2019 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statement about our prospects for growth, intellectual property protection, market size or growth, competitive position, regulatory agency action, and the anticipated development, timing, data readouts and therapeutic scope and value of our development stage products. You should not place undue relianc ...